Skip to main content

Recombinant Mouse Coagulation Factor VII Protein, CF

R&D Systems, part of Bio-Techne | Catalog # 3305-SE

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
3305-SE-010

Key Product Details

Source

CHO

Accession #

Structure / Form

Mature form

Conjugate

Unconjugated

Applications

Enzyme Activity

Product Specifications

Source

Chinese Hamster Ovary cell line, CHO-derived mouse Coagulation Factor VII protein
Ala42-Leu446, with a C-terminal 10-His tag

Purity

>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.

Endotoxin Level

<1.0 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Ala42

Predicted Molecular Mass

47 kDa

SDS-PAGE

58 kDa and 54 kDa, reducing conditions

Activity

Measured by its ability to cleave the fluorogenic peptide substrate Boc-VPR-AMC (Catalog # ES011).
The specific activity, is >4 pmol/min/µg, as measured under the described conditions.

Formulation, Preparation and Storage

3305-SE
Formulation Lyophilized from a 0.2 μm filtered solution in Tris and NaCl.
Reconstitution Reconstitute at 200 μg/mL in sterile 50 mM Tris, 10 mM CaCl2, 150 mM NaCl and 0.05% Brij-35 (pH 7.5).
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -20 to -70 °C as supplied.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: Coagulation Factor VII

Coagulation Factors VII and VIIa refer to the pro and active forms of the same protease, respectively (1). Factor VII is synthesized in the liver and circulates in the plasma where it binds to tissue factor (TF), an integral membrane protein found in a variety of cell types. Upon binding of TF, factor VII is rapidly converted into VIIa. The resulting 1:1 complex of VIIa and TF initiates the coagulation pathway and has also important coagulation-independent functions such as angiognesis (2). The cleavage and activation of Coagulation Factors VII, IX and X by VIIa:TF is phospholipid-dependent whereas the cleavage of small peptide substrates is not (1). The deduced amino acid sequence of mouse factor VII predicts a signal peptide (residues 1 to 24), propeptide (residues 25 to 41), and the mature chain that can be further processed into the light chain (residues 42 to 193) and the heavy chain (residues 194 to 446). The purified recombinant mouse F7 corresponds to the mature chain, which can be processed and activated by treatment with thermolysin and binding with recombinant mouse Tissue Factor (Catalog # http://www.rndsystems.com/product_results.aspx?k=3178-PA">3178-PA) under the conditions described in the Activity Assay Protocol.

References

  1. Morrissey, J.H. (2004) in Handbook of Proteolytic Enzymes, Barrett, A.J. et al. (eds. ), Academic Press, San Diego, p. 1659.
  2. Versteeg, H.H. et al. (2003) Carcinogenesis 24:1009.

Long Name

Coagulation Factor VII (Serum Prothrombin Conversion Accelerator)

Alternate Names

F7

Entrez Gene IDs

2155 (Human); 14068 (Mouse)

Gene Symbol

F7

UniProt

Additional Coagulation Factor VII Products

Product Documents for Recombinant Mouse Coagulation Factor VII Protein, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Recombinant Mouse Coagulation Factor VII Protein, CF

For research use only

Loading...
Loading...
Loading...
Loading...
Loading...